ERBB2 and metastatic malignant neoplasm in the lymph nodes: The HER2-positive (HER2+) subtype has the second-highest TANs density (positivity rate 53%) and is associated with more aggressive clinical features, including larger tumor size, higher histological grade, and elevated lymph node metastasis rates (4).